MindBio Therapeutics
MindBio Therapeutics

MindBio Therapeutics

DR31Ahrefs DR: 31/100. Below median. Measured by Ahrefs. Median 44.Agent67Agent Readiness: 67/100. Top 25%. Measured by StartupHub.ai. Median 41.Speed88Site Speed: 88/100. Top 25%. Measured by Google PageSpeed. Median 62.

AI-powered voice analysis for non-invasive drug and alcohol intoxication detection.

Website
2021ActiveMelbourne, Australia

About

MindBio Therapeutics develops and commercializes AI-powered health prediction technologies that transform human voice into actionable health intelligence. Their proprietary platform analyzes acoustic biomarkers in speech to detect drug and alcohol intoxication, with applications in both consumer and enterprise markets, particularly for safety-critical industries.

Key facts

At-a-glance profile data

Website
mindbiotherapeutics.com
Headquarters
Melbourne, Australia
Founded
2021
Total funding
$2M (Private Placement)
Business model
B2B | B2C

Funding rounds

Funding rounds raised by MindBio Therapeutics
DateRoundAmountLead investors
18 Feb 2026Private Placement$650K-
12 Dec 2025Private Placement$1M-

Tech stack

Detected on mindbiotherapeutics.com, last scanned 29 Sept 2026. Run your own scan

CDN
Cloudflare
Hosting
Render
Email provider
Google Workspace
Add first review

Frequently asked

How much funding has MindBio Therapeutics raised?

MindBio Therapeutics has raised a total of $2M in funding. The most recent round on record is Private Placement.